Chidamide Suppresses the Growth of Cholangiocarcinoma by Inhibiting HDAC3 and Promoting FOXO1 Acetylation

• Asıl Yazarlar: Yongpan Li (Yazar), Jujia Zheng (Yazar), Qiang Huo (Yazar), Zhongchao Chen (Yazar), Jun Chen (Yazar), Xiangwei Xu (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Hindawi Limited, 2022-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Inhibitors for histone deacetylases (HDACs) have been identified as epigenetic drug targets to treat a variety of malignancies through several molecular mechanisms. The present study is aimed at investigating the mechanism underlying the possible antitumor effect of the HDAC inhibitor chidamide (CDM...